Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer
NCT03575637
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
180
Enrollment
OTHER
Sponsor class
Conditions
Gastric Cancer
Interventions
DRUG:
Olanzapine
Sponsor
Peking University